TSN · NYQ · Consumer Defensive
Tyson Foods, Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 51.50
Market price
USD 52.77
Implied upside
-2.4%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 54.8bn | USD 55.2bn | USD 55.6bn | USD 56.0bn | USD 56.4bn | +0.7% |
| EBIT | USD 2.0bn | USD 2.0bn | USD 2.0bn | USD 2.0bn | USD 2.0bn | +0.7% |
| NOPAT | USD 1.5bn | USD 1.6bn | USD 1.6bn | USD 1.6bn | USD 1.6bn | +0.7% |
| Add depreciation & amortisation | USD 1.4bn | USD 1.4bn | USD 1.4bn | USD 1.4bn | USD 1.4bn | +0.7% |
| Less capital expenditure | USD -1.5bn | USD -1.5bn | USD -1.5bn | USD -1.6bn | USD -1.6bn | +0.7% |
| Less increase in working capital | USD -36.7m | USD -37.0m | USD -37.2m | USD -37.5m | USD -37.8m | +0.7% |
| Free cashflow to firm | USD 1.3bn | USD 1.4bn | USD 1.4bn | USD 1.4bn | USD 1.4bn | +0.7% |
| Discount factor | 0.9676 | 0.9058 | 0.8480 | 0.7939 | 0.7432 | - |
| Present value | USD 1.3bn | USD 1.2bn | USD 1.2bn | USD 1.1bn | USD 1.0bn | -5.7% |
| Present Value Of The Forecast | USD 5.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 0.579 | Reported 0.371, pulled toward 1.0 (Blume) |
| Cost of equity | 8.18% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.00% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | USD 18.6bn | 67.8% of capital |
| Total debt | USD 8.8bn | 32.2% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 6.82% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
78% of EV
- Forecast FCFF, final year
- USD 1.4bn
- Capex at depreciation, working capital in reinvestment
- USD 1.8bn
- Less reinvestment at g/ROIC (36.7% of NOPAT)
- USD -661.2m
- Capitalised
- USD 1.1bn
- ROIC (WACC floor)
- 6.8%
- Terminal value, undiscounted
- USD 27.1bn
- Terminal value, discounted
- USD 20.1bn
- Enterprise value
- USD 26.0bn
- Less net debt
- USD 7.6bn
- Equity value
- USD 18.4bn
Exit at 9.3x EBITDA
80% of EV
- Terminal value, undiscounted
- USD 31.9bn
- Terminal value, discounted
- USD 23.7bn
- Enterprise value
- USD 29.5bn
- Less net debt
- USD 7.6bn
- Equity value
- USD 21.9bn
Spread between methods: 18%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.82% | 81.99 | 82.41 | 82.84 | 83.26 | 83.69 |
| 5.82% | 63.78 | 64.12 | 64.45 | 64.79 | 65.13 |
| 6.82% | 50.95 | 51.22 | 51.50 | 51.77 | 52.05 |
| 7.82% | 41.42 | 41.65 | 41.88 | 42.11 | 42.35 |
| 8.82% | 34.08 | 34.28 | 34.47 | 34.67 | 34.87 |
Outlined: this model. Green text: above today's price of 52.77. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 0.7% | 1.2% | +0.5pp |
| EBIT margin | 3.6% | 3.6% | +0.1pp |
| Discount rate | 6.8% | 6.7% | -0.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.